TGY2IT
RLAY icon

Timothy G. Youngquist 2020 Irrevocable Trust’s Relay Therapeutics RLAY Stock Holding History

Timothy G. Youngquist 2020 Irrevocable Trust’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15M Buy
801,464
+302,406
+61% +$4.39M 2.94% 4
2026
Q1 		$4.97M Hold
499,058
– – 2.14% 7
2025
Q4 		$4.22M Buy
+499,058
New +$3.56M 3.09% 11

Other funds holding RLAY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Timothy G. Youngquist 2020 Irrevocable Trust's RLAY Position: Q2 2026 in Review

Timothy G. Youngquist 2020 Irrevocable Trust increased its Relay Therapeutics (RLAY) stake by 61% in Q2 2026, buying an estimated $4.39M and bringing the position to 801,464 shares worth $15M. The position accounts for 2.94% of the portfolio, ranked #4.

Timothy G. Youngquist 2020 Irrevocable Trust first reported a position in RLAY in Q4 2025 and has held it in 3 quarters since. 74 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Timothy G. Youngquist 2020 Irrevocable Trust held 801,464 shares of Relay Therapeutics worth $15M as of Q2 2026.
  • Timothy G. Youngquist 2020 Irrevocable Trust bought 302,406 Relay Therapeutics shares in Q2 2026, an estimated $4.39M.
  • Relay Therapeutics made up 2.94% of Timothy G. Youngquist 2020 Irrevocable Trust's portfolio in Q2 2026, its #4 holding.
  • Timothy G. Youngquist 2020 Irrevocable Trust first reported a position in Relay Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 74 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Timothy G. Youngquist 2020 Irrevocable Trust's 13F filing for Q2 2026, filed 7 Aug 2026.